Long-term trends in the incidence of heart failure after myocardial infarction

Raghava S Velagaleti1, Michael J Pencina, Joanne M Murabito

  • 1National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA 01702-5803, USA.

Circulation
|October 29, 2008
PubMed

Insights

Heart failure incidence after myocardial infarction (MI) has increased significantly in recent decades, despite declining MI mortality rates. This study highlights a growing burden of heart failure post-MI in the community.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Myocardial infarction (MI) mortality has decreased in the US.
  • Limited community-based research exists on long-term heart failure incidence post-MI.
  • Previous findings on heart failure trends post-MI are conflicting.

Purpose of the Study:

  • To investigate long-term trends in heart failure incidence after myocardial infarction (MI).
  • To compare heart failure incidence and mortality rates across three decades.
  • To assess the risk of heart failure in recent decades compared to an earlier period.

Main Methods:

  • Analysis of 676 Framingham Heart Study participants aged 45-85 with a first MI between 1970-1999.
  • Assessment of heart failure and mortality incidence rates in three decades: 1970-1979, 1980-1989, 1990-1999.
  • Multivariable-adjusted risk estimation for events in later decades relative to 1970-1979.

Main Results:

  • 30-day heart failure incidence post-MI rose from 10% (1970-1979) to 23.1% (1990-1999).
  • 5-year heart failure incidence post-MI increased from 27.6% to 31.9% across the same periods.
  • 30-day and 5-year mortality rates after MI significantly declined from 1970-1979 to 1990-1999.

Conclusions:

  • Heart failure incidence post-myocardial infarction has increased in recent decades.
  • This rise in heart failure incidence parallels the observed decrease in MI mortality.
  • Community-based data indicate a growing challenge of heart failure management after MI.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.